相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis
Joanne Chiu et al.
CANCER (2012)
First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study
R. Lencioni et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
Jeong Eun Kim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
Hwi Young Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models
Kyung Kee Baek et al.
ONCOLOGY (2011)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area
Ju Hyun Shim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
Marcus Alexander Wörns et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Role of sorafenib in HCC patients with compromised liver function
Massimo Di Maio et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis
Matthias Pinter et al.
ONCOLOGIST (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Natural history of patients hospitalized for management of cirrhotic ascites
Ramon Planas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
Current concepts -: Management of cirrhosis and ascites
P Ginès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
